Norges Bank Revolution Medicines, Inc. Transaction History

Norges Bank

$772 Billion
Q2 2025

A detailed history of Norges Bank transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Norges Bank holds 1,701,111 shares of RVMD stock, worth $60 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,701,111

Holding current value

$60 Million

% of portfolio

0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$31.13 - $41.98 $53 Million - $71.4 Million	1,701,111 New	1,701,111 $62.6 Million
Q4 2024 Feb 12, 2025	BUY	$42.97 - $60.6 $74.9 Million - $106 Million	1,742,039 New	1,742,039 $76.2 Million
Q2 2024 Aug 14, 2024	BUY	$30.14 - $40.68 $55.7 Million - $75.2 Million	1,848,647 New	1,848,647 $71.7 Million
Q1 2024 May 14, 2025	BUY	$26.56 - $33.55 $45.4 Million - $57.3 Million	1,708,276 New	1,708,276 $55.1 Million
Q4 2023 Feb 09, 2024	BUY	$18.35 - $34.12 $5.17 Million - $9.61 Million	281,705 New	281,705 $8.08 Million
Q3 2023 Nov 13, 2024	BUY	$25.17 - $35.05 $11.1 Million - $15.4 Million	439,687 New	439,687 $12.2 Million
Q3 2023 Nov 13, 2023	SELL	$25.17 - $35.05 $14 Million - $19.4 Million	-554,741 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$20.28 - $27.0 $30 Million - $40 Million	-1,481,160 Reduced 80.12%	367,487 $9.83 Million
Q2 2023 Aug 14, 2023	SELL	$20.28 - $27.0 $9.98 Million - $13.3 Million	-492,007 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$20.76 - $30.09 $10.7 Million - $15.5 Million	514,016 New	514,016 $11.1 Million
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $11 Million - $15.9 Million	622,641 New	622,641 $14.8 Million
Q3 2022 Nov 13, 2023	BUY	$17.46 - $26.0 $9.69 Million - $14.4 Million	554,741 New	554,741 $10.9 Million
Q2 2022 Aug 14, 2023	BUY	$14.54 - $27.17 $7.15 Million - $13.4 Million	492,007 New	492,007 $9.59 Million
Q1 2022 May 12, 2023	SELL	$17.31 - $26.4 $2.6 Million - $3.96 Million	-150,090 Reduced 24.11%	472,551 $12.1 Million
Q1 2022 May 09, 2022	SELL	$17.31 - $26.4 $7.95 Million - $12.1 Million	-459,043 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$24.35 - $33.7 $11.2 Million - $15.5 Million	459,043 New	459,043 $11.6 Million
Q3 2021 Nov 14, 2022	BUY	$23.95 - $33.41 $9.72 Million - $13.6 Million	405,966 New	405,966 $11.2 Million
Q3 2021 Nov 05, 2021	SELL	$23.95 - $33.41 $2.07 Million - $2.89 Million	-86,566 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$29.0 - $47.44 $2.51 Million - $4.11 Million	86,566 New	86,566 $2.75 Million
Q2 2021 Aug 10, 2021	SELL	$29.0 - $47.44 $4.89 Million - $8 Million	-168,734 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$37.21 - $54.43 $6.28 Million - $9.18 Million	168,734 New	168,734 $7.74 Million
Q3 2020 Nov 10, 2020	SELL	$22.61 - $34.8 $1.09 Million - $1.68 Million	-48,245 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$19.65 - $39.34 $948,014 - $1.9 Million	48,245 New	48,245 $1.52 Million
Q2 2020 Aug 07, 2020	SELL	$19.65 - $39.34 $1.38 Million - $2.75 Million	-70,000 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$20.0 - $34.08 $1.4 Million - $2.39 Million	70,000 New	70,000 $1.53 Million

Others Institutions Holding RVMD

# of Institutions

331

Shares Held

195M

Call Options Held

908K

Put Options Held

723K

Vanguard Group Inc Valley Forge, PA

15.8M
Shares

$556 Million
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

14.3M
Shares

$505 Million
2.37% of portfolio
Black Rock Inc. New York, NY

13.4M
Shares

$473 Million
0.01% of portfolio
Janus Henderson Group PLC London, X0

10.6M
Shares

$373 Million
0.2% of portfolio
Wellington Management Group LLP Boston, MA

10.3M
Shares

$362 Million
0.07% of portfolio

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.09B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account